Artal Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Artal Group’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-750,000	Closed	-$38.4M	–	165
2021 Q1	$38.4M	Buy	750,000 +100,000	+15%	+$6.02M	0.68%	34
2020 Q4	$40.2M	Buy	+650,000	New	+$37.2M	0.86%	31
2018 Q1	–	Sell	-500,000	Closed	-$2.98M	–	140
2017 Q4	$2.98M	Hold	500,000	–	–	0.04%	87
2017 Q3	$3.71M	Hold	500,000	–	–	0.06%	72
2017 Q2	$4.68M	Sell	500,000 -46,278	-8%	-$340K	0.08%	66
2017 Q1	$3.98M	Hold	546,278	–	–	0.09%	67
2016 Q4	$4.04M	Sell	546,278 -653,722	-54%	-$4.71M	0.09%	58
2016 Q3	$7.25M	Buy	1,200,000 +300,000	+33%	+$1.42M	0.14%	43
2016 Q2	$4.04M	Hold	900,000	–	–	0.08%	47
2016 Q1	$2.24M	Hold	900,000	–	–	0.04%	51
2015 Q4	$7.29M	Hold	900,000	–	–	0.14%	56
2015 Q3	$5.45M	Hold	900,000	–	–	0.12%	54
2015 Q2	$7.41M	Buy	900,000 +100,000	+13%	+$794K	0.32%	50
2015 Q1	$6.04M	Buy	800,000 +400,000	+100%	+$3.13M	0.28%	55
2014 Q4	$2.73M	Buy	400,000 +125,000	+45%	+$661K	0.1%	80
2014 Q3	$1.24M	Hold	275,000	–	–	0.05%	84
2014 Q2	$1.61M	Hold	275,000	–	–	0.07%	81
2014 Q1	$1.82M	Hold	275,000	–	–	0.07%	92
2013 Q4	$1.59M	Hold	275,000	–	–	0.06%	81
2013 Q3	$1.53M	Hold	275,000	–	–	0.05%	77
2013 Q2	$3.89M	Buy	+275,000	New	+$3.56M	0.12%	78

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artal Group's CCXI Position: Q2 2021 in Review

Artal Group sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 750,000 shares — an estimated $38.4M sold.

Artal Group first reported a position in CCXI in Q2 2013 and held it in 21 quarters. The position peaked at $40.2M in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

Artal Group reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
Artal Group sold 750,000 ChemoCentryx, Inc. shares in Q2 2021, an estimated $38.4M.
Artal Group first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 21 quarters.
Artal Group's ChemoCentryx, Inc. position peaked at $40.2M in Q4 2020.
146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Artal Group's 13F filing for Q2 2021, filed 13 Aug 2021.